Dose–response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy
- 1 March 2005
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 61 (3) , 656-664
- https://doi.org/10.1016/j.ijrobp.2004.06.022
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation TherapyJournal of Clinical Oncology, 2002
- Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinomaCancer, 2001
- Chemoradiotherapy of Locally Advanced Esophageal CancerJAMA, 1999
- Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.Journal of Clinical Oncology, 1998
- Unresectable nonmetastatic squamous cell carcinoma of the esophagus managed by sequential chemotherapy (cisplatin and bleomycin) and radiation therapyCancer, 1993
- Prolonged chemotherapy for localised squamous carcinoma of the oesophagusEuropean Journal Of Cancer, 1992
- Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Radiotherapy alone and chemoradiation for nonmetastaticCancer, 1989
- Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958